| High-contrast in vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies K Tagai, M Ono, M Kubota, S Kitamura, K Takahata, C Seki, Y Takado, ... Neuron 109 (1), 42-58. e8, 2021 | 219 | 2021 |
| It’s not my fault: postdictive modulation of intentional binding by monetary gains and losses K Takahata, H Takahashi, T Maeda, S Umeda, T Suhara, M Mimura, ... PloS one 7 (12), e53421, 2012 | 153 | 2012 |
| Discrepancy between explicit judgement of agency and implicit feeling of agency: Implications for sense of agency and its disorders N Saito, K Takahata, T Murai, H Takahashi Consciousness and cognition 37, 1-7, 2015 | 114 | 2015 |
| Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I T Sasaki, H Ito, Y Kimura, R Arakawa, H Takano, C Seki, F Kodaka, ... Journal of Nuclear Medicine 53 (7), 1065-1073, 2012 | 107 | 2012 |
| Reduced sense of agency in chronic schizophrenia with predominant negative symptoms T Maeda, K Takahata, T Muramatsu, T Okimura, A Koreki, S Iwashita, ... Psychiatry research 209 (3), 386-392, 2013 | 90 | 2013 |
| PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury K Takahata, Y Kimura, N Sahara, S Koga, H Shimada, M Ichise, F Saito, ... Brain 142 (10), 3265-3279, 2019 | 73 | 2019 |
| Norepinephrine transporter in major depressive disorder: a PET study S Moriguchi, M Yamada, H Takano, T Nagashima, K Takahata, ... American Journal of Psychiatry 174 (1), 36-41, 2017 | 65 | 2017 |
| Superiority illusion arises from resting-state brain networks modulated by dopamine M Yamada, LQ Uddin, H Takahashi, Y Kimura, K Takahata, R Kousa, ... Proceedings of the National Academy of Sciences 110 (11), 4363-4367, 2013 | 60 | 2013 |
| Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies T Tezuka, K Takahata, M Seki, H Tabuchi, Y Momota, M Shiraiwa, ... Brain Communications 3 (4), fcab190, 2021 | 55 | 2021 |
| Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C] DASB and (S, S … T Nogami, H Takano, R Arakawa, T Ichimiya, H Fujiwara, Y Kimura, ... International Journal of Neuropsychopharmacology 16 (5), 937-943, 2013 | 50 | 2013 |
| Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease S Kitamura, H Shimada, F Niwa, H Endo, H Shinotoh, K Takahata, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (11), 1208-1214, 2018 | 42 | 2018 |
| Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study M Kubota, J Fujino, S Tei, K Takahata, K Matsuoka, K Tagai, Y Sano, ... Cerebral Cortex 30 (12), 6458-6468, 2020 | 40 | 2020 |
| Neural mechanism underlying autistic savant and acquired savant syndrome K Takahata, M Kato Brain and nerve= Shinkei kenkyu no shinpo 60 (7), 861-869, 2008 | 38 | 2008 |
| Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA H Ito, H Takano, R Arakawa, H Takahashi, F Kodaka, K Takahata, ... Public Library of Science 7 (9), e46488, 2012 | 37 | 2012 |
| Altered awareness of action in Parkinson’s disease: evaluations by explicit and implicit measures N Saito, K Takahata, H Yamakado, N Sawamoto, S Saito, R Takahashi, ... Scientific Reports 7 (1), 8019, 2017 | 36 | 2017 |
| Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies M Kubota, S Moriguchi, K Takahata, S Nakajima, N Horita Schizophrenia research 222, 122-132, 2020 | 32 | 2020 |
| Quantitative analysis of amyloid deposition in Alzheimer disease using PET and the radiotracer 11C-AZD2184 H Ito, H Shimada, H Shinotoh, H Takano, T Sasaki, T Nogami, M Suzuki, ... Journal of Nuclear Medicine 55 (6), 932-938, 2014 | 30 | 2014 |
| Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2 H Takano, R Arakawa, T Nogami, M Suzuki, T Nagashima, H Fujiwara, ... International Journal of Neuropsychopharmacology 17 (4), 553-560, 2014 | 30 | 2014 |
| Affinity states of striatal dopamine D2 receptors in antipsychotic-free patients with schizophrenia M Kubota, T Nagashima, H Takano, F Kodaka, H Fujiwara, K Takahata, ... International Journal of Neuropsychopharmacology 20 (11), 928-935, 2017 | 29 | 2017 |
| Excess tau PET ligand retention in elderly patients with major depressive disorder S Moriguchi, K Takahata, H Shimada, M Kubota, S Kitamura, Y Kimura, ... Molecular Psychiatry 26 (10), 5856-5863, 2021 | 28 | 2021 |
Yasuyuki KimuraNational Center for Geriatrics and GerontologyEmail verificata su ncgg.go.jp
